Evelyn Partners’s Zimmer Biomet ZBH Stock Holding History

Evelyn Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.11K	Hold	80	–	–	﹤0.01%	590
2026 Q2	$6.89K	Buy	+80	New	+$7.02K	﹤0.01%	494

Other funds holding ZBH

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return

Evelyn Partners's ZBH Position: Q3 2026 in Review

Evelyn Partners held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 80 shares worth $7.11K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Evelyn Partners first reported a position in ZBH in Q2 2026 and has held it in 2 quarters since. 778 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Evelyn Partners held 80 shares of Zimmer Biomet worth $7.11K as of Q3 2026.
Evelyn Partners left its Zimmer Biomet share count unchanged in Q3 2026.
Zimmer Biomet made up ﹤0.01% of Evelyn Partners's portfolio in Q3 2026, its #590 holding.
Evelyn Partners first reported a position in Zimmer Biomet in Q2 2026 and has held it in 2 quarters since.
778 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.